News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,731 Results
Type
Article (13946)
Company Profile (305)
Press Release (247480)
Section
Business (79364)
Career Advice (151)
Deals (13191)
Drug Delivery (34)
Drug Development (50328)
Employer Resources (31)
FDA (5682)
Job Trends (5117)
News (144144)
Policy (10018)
Tag
Academia (901)
Alliances (21528)
Alzheimer's disease (756)
Approvals (5661)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4522)
Biotechnology (250)
Breast cancer (109)
Cancer (888)
Cardiovascular disease (71)
Career advice (132)
CAR-T (73)
Cell therapy (217)
Clinical research (40137)
Collaboration (308)
Compensation (128)
COVID-19 (1006)
C-suite (78)
Cystic fibrosis (66)
Data (983)
Diabetes (85)
Diagnostics (1207)
Drug discovery (56)
Earnings (29004)
Events (47196)
Executive appointments (249)
FDA (6047)
Funding (306)
Gene editing (63)
Gene therapy (163)
GLP-1 (310)
Government (1065)
Healthcare (6543)
Infectious disease (1043)
Inflammatory bowel disease (98)
IPO (7197)
Job creations (860)
Job search strategy (127)
Layoffs (188)
Legal (1375)
Lung cancer (130)
Lymphoma (62)
Manufacturing (86)
Medical device (2558)
Medtech (2559)
Mergers & acquisitions (6129)
Metabolic disorders (257)
Neuroscience (999)
NextGen Class of 2024 (2004)
Non-profit (847)
Northern California (1091)
Obesity (140)
Opinion (91)
Parkinson's disease (75)
Patents (61)
People (25107)
Phase I (14150)
Phase II (18664)
Phase III (11818)
Pipeline (367)
Postmarket research (851)
Preclinical (5971)
Radiopharmaceuticals (205)
Rare diseases (201)
Real estate (1412)
Regulatory (8281)
Research institute (931)
Southern California (976)
Startups (1964)
United States (8658)
Vaccines (164)
Weight loss (83)
Date
Today (23)
Last 7 days (364)
Last 30 days (1469)
Last 365 days (20553)
2024 (20445)
2023 (22413)
2022 (26822)
2021 (27805)
2020 (23358)
2019 (16225)
2018 (11739)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10394)
2013 (7484)
2012 (7532)
2011 (7617)
2010 (7431)
Location
Africa (146)
Asia (16927)
Australia (2856)
California (2474)
Canada (809)
China (203)
Colorado (91)
Connecticut (104)
Europe (36448)
Florida (271)
Georgia (72)
Illinois (153)
Indiana (61)
Kansas (55)
Maryland (330)
Massachusetts (1955)
Minnesota (101)
New Jersey (630)
New York (682)
North Carolina (419)
Northern California (1091)
Ohio (82)
Pennsylvania (474)
South America (207)
Southern California (976)
Texas (278)
Washington State (247)
261,731 Results for "bioxcel therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioXcel Therapeutics to Present at ThinkEquity Conference
October 29, 2024
·
5 min read
Press Releases
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
November 15, 2024
·
14 min read
Press Releases
BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering
November 22, 2024
·
5 min read
Pharm Country
BioXcel Therapeutics to Present at Jefferies 2024 Global Healthcare Conference
BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, announced that CEO Vimal Mehta, Ph.D., will present at the Jefferies Global Healthcare Conference in New York City.
May 28, 2024
·
9 min read
Press Releases
BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
November 8, 2024
·
3 min read
Business
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, announced its financial results for the first quarter of 2024.
May 9, 2024
·
16 min read
Business
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
BioXcel Therapeutics, Inc. today announced that it will release its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets.
April 25, 2024
·
4 min read
Pharm Country
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
BioXcel Therapeutics, Inc. announced that Rob Risinger, M.D., Chief Medical Officer of Neuroscience, will deliver oral and poster presentations at the 2024 American Society of Clinical Psychopharmacology Annual Meeting.
May 21, 2024
·
9 min read
Business
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
BioXcel Therapeutics, Inc. provided an update on its late-stage TRANQUILITY and SERENITY clinical programs.
March 12, 2024
·
18 min read
Pharm Country
BioXcel Therapeutics Announces Positive Topline Results from Post-Marketing Requirement Study Evaluating PRN Treatment of IGALMI™ (dexmedetomidine) Sublingual Film for Agitation Associated with Bipolar Disorders or Schizophrenia
BioXcel Therapeutics, Inc. today announced positive topline results from a post-marketing requirement (PMR) study of IGALMI™ (dexmedetomidine) sublingual film that demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with the 180 mcg dose after seven days of PRN (as-needed) treatment.
June 25, 2024
·
11 min read
1 of 26,174
Next
